• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Adjunctive technique improves sensitivity, specificity

Article

A new method of computer-aided evaluation makes it easier to differentiate between benign and malignant lesions on MR scans, possibly reducing the number of false positives and unnecessary biopsies.

Other findings include:

  • Computer-aided detection is no match for a dedicated breast imaging specialist, according to a large comparative study of 5875 consecutive screening mammograms performed at Yale's Breast Imaging Center.

  • Breast MR spectroscopy as an adjunct to breast MR may cut the rate of false positives related to the stage of a woman's menstrual cycle.

  • In the Digital Mammographic Imaging Screening Trial (DMIST), 40% of the women over 50 had dense breasts, indicating that digital screening could benefit older as well as younger women.

  • DMIST researchers plan to investigate why there was a difference between digital and film-based screening and will also perform a cost-effectiveness study for digital imaging.
Recent Videos
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Related Content
© 2025 MJH Life Sciences

All rights reserved.